Home / Market Reports / Medical Care / Global Decentralized & Digitalized Clinical Trials Market Growth (Status and Outlook) 2024-2030

Global Decentralized & Digitalized Clinical Trials Market Growth (Status and Outlook) 2024-2030

Global Decentralized & Digitalized Clinical Trials Market Growth (Status and Outlook) 2024-2030

Product Code:1242612

Published Date: Dec 05,2024

Pages: 156

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Decentralized & Digitalized Clinical Trials market size is predicted to grow from US$ 8928 million in 2024 to US$ 17460 million in 2030; it is expected to grow at a CAGR of 11.8% from 2024 to 2030.

Decentralized & Digitalized Clinical Trials are an innovative approach to conducting clinical research. They aim to move away from the traditional model that requires participants to visit a central research site (such as a hospital or a dedicated research facility) for most of the trial - related activities. Instead, DCTs bring various aspects of the trial to the participants' local environment, such as their homes or local healthcare centers.

United States market for Decentralized & Digitalized Clinical Trials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Decentralized & Digitalized Clinical Trials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Decentralized & Digitalized Clinical Trials is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Decentralized & Digitalized Clinical Trials players cover Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “Decentralized & Digitalized Clinical Trials Industry Forecast” looks at past sales and reviews total world Decentralized & Digitalized Clinical Trials sales in 2023, providing a comprehensive analysis by region and market sector of projected Decentralized & Digitalized Clinical Trials sales for 2024 through 2030. With Decentralized & Digitalized Clinical Trials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Decentralized & Digitalized Clinical Trials industry.

This Insight Report provides a comprehensive analysis of the global Decentralized & Digitalized Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Decentralized & Digitalized Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Decentralized & Digitalized Clinical Trials market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Decentralized & Digitalized Clinical Trials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Decentralized & Digitalized Clinical Trials.

This report presents a comprehensive overview, market shares, and growth opportunities of Decentralized & Digitalized Clinical Trials market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Web-based
    Cloud-based

Segmentation by Application:
    Oncology
    Cardiovascular
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Medidata
    IQVIA
    Labcorp
    PRA Health Sciences
    Parexel
    ICON
    Oracle
    Medpace
    Patheon
    Signant Health
    Syneos Health
    CRF Health
    Clinical Ink
    Medable
    Obvio Health
    Fortrea
    ProPharma
    Cloudbyz
    Science 37
    Advarra
    Medrio
    Tigermed
    Zhejiang Taimei Medical Technology
    Shanghai Yaocheng Health Technology